BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
83 hedge funds and large institutions have $230M invested in Bellicum Pharmaceuticals, Inc. in 2015 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
31% less capital invested
Capital invested by funds: $334M → $230M (-$104M)
Holders
83
Holding in Top 10
–
Calls
$2.06M
Puts
$2.5M
Top Buyers
| 1 | +$6.77M | |
| 2 | +$4.62M | |
| 3 | +$4.56M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.49M |
| 5 |
JPMorgan Chase & Co
New York
|
+$3.88M |
Top Sellers
| 1 | -$10.7M | |
| 2 | -$10.3M | |
| 3 | -$5.87M | |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$5.58M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$5.07M |